68ga-dotanoc and Carcinoma--Hepatocellular

68ga-dotanoc has been researched along with Carcinoma--Hepatocellular* in 1 studies

Other Studies

1 other study(ies) available for 68ga-dotanoc and Carcinoma--Hepatocellular

Article	Year
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:3 Ga-DOTANOC PET/CT confirmed somatostatin receptor (SR) expression in hypervascularized liver lesions suggestive of neuroendocrine tumor that was later diagnosed as hepatocellular carcinoma (HCC). Being highly vascularized on CT, HCC lesions may mimic neuroendocrine tumors. Although HCC is not included among current indications for SR-PET/CT imaging, it may represent a pitfall in image interpretation when studying neuroendocrine tumor patients. Further studies are needed to better ascertain the potential diagnostic role of SR-imaging in HCC. Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2019

Article

Year

68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma.

Clinical nuclear medicine, 2019, Volume: 44, Issue:3

Ga-DOTANOC PET/CT confirmed somatostatin receptor (SR) expression in hypervascularized liver lesions suggestive of neuroendocrine tumor that was later diagnosed as hepatocellular carcinoma (HCC). Being highly vascularized on CT, HCC lesions may mimic neuroendocrine tumors. Although HCC is not included among current indications for SR-PET/CT imaging, it may represent a pitfall in image interpretation when studying neuroendocrine tumor patients. Further studies are needed to better ascertain the potential diagnostic role of SR-imaging in HCC.

Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2019